Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Type 2 Diabetes Mellitus (T2DM)
Clinical trial register · Taiwan

Type 2 Diabetes Mellitus (T2DM) Trials in Taiwan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2861 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2861
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 4 Taichung 3 Kaohsiung City 1 Tainan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Taipei4 Taichung3 Kaohsiung City1 Tainan1
All 4 locations
Target enrolment
to

Type 2 Diabetes Mellitus (T2DM) trials in Taiwan

7 of 2861 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Not yet open
Chung Shan Medical University
Observational
71,775
Taichung
2026-07-31
Not yet open
National Taiwan University Hospital
Not applicable
400
Taipei
2026-07
Recruiting
Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
NCT07398495Type 2 Diabetes Mellitus (T2DM), Sarcopenia
yueh chu wu
Not applicable
128
Taichung
2026-02-23
Recruiting
Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Sectional Study
NCT07241325Type 2 Diabetes Mellitus (T2DM), Health-related Quality of Life, Depressive Symptoms, Psychological Well-being
National Taiwan University Hospital
Observational
500
Taipei
2025-09-19
Active, closed
Chung Shan Medical University
Not applicable
66
Taichung
2025-08-18
Not yet open
Essential Oil-Assisted Respiratory Training in Type 2 Diabetic Patients With Lung Infections
NCT07103460Type 2 Diabetes Mellitus (T2DM), Pulmonary Infections, Pneumonia
National Taipei University of Nursing and Health Sciences
Not applicable
100
Taipei
2025-07-25
Active, closed
Amgen
Phase 2
409
Kaohsiung City, Tainan, Taipei
2024-11-07
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-taiwan/condition/type-2-diabetes-mellitus-t2dm

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,861 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies listing the condition Type 2 Diabetes Mellitus (T2DM).

How many Type 2 Diabetes Mellitus (T2DM) trials are recruiting in Taiwan?

2 of the 7 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Type 2 Diabetes Mellitus (T2DM)), 7 studies
PhaseStudiesRecruitingShare
Not applicable4157.1%
Observational2128.6%
Phase 21014.3%

Most active sponsors

Lead sponsors with the most studies (Type 2 Diabetes Mellitus (T2DM))
Lead sponsorStudiesRecruiting
Chung Shan Medical University20
National Taiwan University Hospital21
Amgen10
National Taipei University of Nursing and Health Sciences10
yueh chu wu11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.